Giordano, G., Febbraro, A., Tomaselli, E., Sarnicola, M. L., Parcesepe, P., Parente, D., . . . Pancione, M. (2015). Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer. J Exp Clin Cancer Res.
Chicago-stil citatGiordano, Guido, et al. "Cancer-related CD15/FUT4 Overexpression Decreases Benefit to Agents Targeting EGFR or VEGF Acting As a Novel RAF-MEK-ERK Kinase Downstream Regulator in Metastatic Colorectal Cancer." J Exp Clin Cancer Res 2015.
MLA-referensGiordano, Guido, et al. "Cancer-related CD15/FUT4 Overexpression Decreases Benefit to Agents Targeting EGFR or VEGF Acting As a Novel RAF-MEK-ERK Kinase Downstream Regulator in Metastatic Colorectal Cancer." J Exp Clin Cancer Res 2015.